Surrogate endpoints in suicide research

Suicide and Life-Threatening Behavior

Volumn 40, Issue 5, 2010, Pages 500-505

  Wortzel, Hal S ^a   Gutierrez, Peter M ^a   Homaifar, Beeta Y ^a   Breshears, Ryan E ^a   Harwood, Jeri E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BEHAVIORAL RESEARCH; HUMAN; METHODOLOGY; PSYCHOLOGICAL ASPECT; STATISTICS; SUICIDE; SUICIDE ATTEMPT;

BEHAVIORAL RESEARCH; BIOLOGICAL MARKERS; HUMANS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 78650361705     PISSN: 03630234     EISSN: None     Source Type: Journal    
DOI: 10.1521/suli.2010.40.5.500     Document Type: Article

References (25)

1. ABOULKER, J. P., & SWART, A. M. (1993). Preliminary analysis of the Concorde trial: Concorde Coordinating Committee. Lancet, 341, 889-890.
2. ANGUELOVA, M., BENKELFAT, C., & TURECKI, G. (2003). A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Molecular Psychiatry, 8, 646-653. (Pubitemid 36976297)
3. BAKER, S. G. (2006). Surrogate endpoints: Wishful thinking or reality? Journal of the National Cancer Institute, 98, 502-503.
4. BAKER, S. G., & KRAMER, B. S. (2003). A perfect correlate does not a surrogate make. British Medical College Medical Research Methodology, 3, 16-20.
5. BALDESSARINI, R. J., & HENNEN, J. (2004). Genetics of suicide: An overview. Harvard Review of Psychiatry, 12, 1-13.
6. BECHARA, A., DAMASIO, H., DAMASIO, A. R., & LEE, G. P. (1999). Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. Journal of Neuroscience, 19, 5473-5481.
7. BECK, A. T., BECK, R., & KOVACS, M. (1975). Classification of suicidal behaviors: I. Quantifying intent and medical lethality. American Journal of Psychiatry, 132, 285-287.
8. BRENT, D. A., BRIDGE, J., JOHNSON, B. A., & CONNOLLY, J. (1996). Suicidal behavior runs in families: A controlled family study of adolescent suicide victims. Archives of General Psychiatry, 53, 1145-1152.
9. BREZO, J., KLEMPAN, T., & TURECKI, G. (2008). The genetics of suicide: A critical review of molecular studies. Psychiatric Clinics of North America, 31, 179-203.
10. CHESSICK, C. A., PERLICK, D. A., MIKLOWITZ, D. J., KACZYNSKI, R., ALLEN, M. H., MORRIS, C. D., ET AL. (2007). Current suicide ideation and prior suicide attempts of bipolar patients as influences on caregiver burden. Suicide and Life-Threatening Behavior, 37, 482-491.
11. CREMNITER, D., JAMAIN, S., KOLLENBACH, K., ALVAREZ, J. C., LECRUBIER, Y., GILTON, A., ET AL. (1999). CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biological Psychiatry, 45, 1572-1579.
12. FLEMING, T. R., & DEMETS, D. L. (1996). Surrogate end points in clinical trials: Are we being misled? Annals of Internal Medicine, 125, 605-613.
13. JOLLANT, F., BELLIVIER, F., LEBOYER, M., ASTRUC, B., TORRES, S., VERDIER, R., ET AL. (2005). Impaired decision making in suicide attempters. American Journal of Psychiatry, 162, 304-310.
14. LECRUBIER, Y., BRACCONIER, A., SAID, S., & PAYAN, C. (1995). The Impulsivity Rating Scale (IRS): Preliminary results. European Psychiatry, 10, 331-338.
15. LINEHAN, M. M. (2009). Moving forward: Key treatment and intervention research studies needed. Plenary panel address to the annual conference of the American Association of Suicidology, San Francisco, CA.
16. MANN, J. J., & MALONE, K. M. (1997). Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biological Psychiatry, 41, 162-171.
17. MULLER-OERLINGHAUSEN, B., & ROGGENBACH, J. (2002). Concretism in biological suicide research-Are we eating the menu instead of the meal? Some thoughts on present research strategies. Pharmacopsychiatry, 35, 44-49.
18. O'CARROLL, P. W., BERMAN, A. L., MARIS, R. W., MOSCICKI, E. K., TANNEY, B. L., & SILVERMAN, M. M. (1996). Beyond the tower of Babel: A nomenclature for suicidology. Suicide and Life-Threatening Behavior, 26, 237-252.
19. OQUENDO, M. A., PLACIDI, G. P., MALONE, K. M., CAMPBELL, C., KEILP, J., BRODSKY, B., ET AL. (2003). Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Archives of General Psychiatry, 60, 14-22.
20. PRENTICE, R. L. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistical Medicine, 8, 431-440.
21. RILKE, O., SAFAR, C., ISRAEL, M., BARTH, T., FELBER, W., & OEHLER, J. (1998). Differences in whole blood serotonin levels based on a typology of parasuicide. Neuropsychobiology, 38(2), 70-72.
22. SILVERMAN, M. M., BERMAN, A. L., SANDDAL, N. D., O'CARROLL P, W., & JOINER, T. E. (2007a). Rebuilding the tower of Babel: A revised nomenclature for the study of suicide and suicidal behaviors. Part 1: Background, rationale, and methodology. Suicide and Life-Threatening Behavior, 37, 248-263.
23. SILVERMAN, M. M., BERMAN, A. L., SANDDAL, N. D., O'CARROLL P, W., & JOINER, T. E. (2007b). Rebuilding the tower of Babel: A revised nomenclature for the study of suicide and suicidal behaviors. Part 2: Suicide-related ideations, communications, and behaviors. Suicide and Life-Threatening Behavior, 37, 264-277.
24. SUN, F. K., & LONG, A. (2008). A theory to guide families and carers of people who are at risk of suicide. Journal of Clinical Nursing, 17, 1939-1948.
25. YANG, B., & LESTER, D. (2007). Recalculating the economic cost of suicide. Death Studies, 31, 351-361.